RA'ANANA, Israel, Dec. 18,
2023 /PRNewswire/ --
Inspira Technologies OXY BHN Ltd.
(Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"),
a pioneer in life support technology with a vision to
supersede traditional mechanical ventilators, today announced that
its CEO and the Company's President will attend the upcoming
42nd Annual J.P. Morgan Healthcare Conference taking
place January 8-11, 2024 in
San Francisco,
California.
To schedule one on one meeting, please contact
us at: info@inspirao2.com
The Company co-founders, CEO, Dagi Ben-Noon, and
President, Joe Hayon, are scheduled
to meet with both medical device and strategic consulting companies
at the J.P. Morgan Healthcare Conference. This is ahead of the
expected U.S. Food and Drug Administration (FDA) Clearance of the
Inspira life support device that directly oxygenates blood, in the
first half of 2024.
Dagi Ben-Noon, CEO of Inspira Technologies,
remarked, "Following the recent
unveiling of our device at the Extracorporeal Life Support
Organization conference, many companies in the life support
industry have acknowledged our capabilities, establishing the
grounds for potential strategic advances. We are possibly just
months away from FDA clearance, and the industry is
watching."
About J.P. Morgan Healthcare
Conference
The J.P Morgan Healthcare Conference is the industry's
biggest gathering, bringing together more than 8,000 investors,
industry professionals, senior government officials and 550 global
healthcare companies — ranging from Fortune 100 corporations to
small-cap and emerging private companies — to discuss the latest
market trends and medical innovations.
Inspira Technologies OXY BHN Ltd.
Inspira Technologies is targeting to lead the way in
transforming life-support care. Its innovative solutions are paving
the way for direct blood oxygenation, bypassing the lungs, and
potentially reducing the need for traditional mechanical
ventilation. Beyond this, the Company is committed to advancing
blood circulation technology and incorporating AI-driven monitoring
systems. These advancements are part of its strategy to offer more
patient-focused, data-informed care. The integration of these
technologies signifies the potential to enhance patient outcomes
and streamline hospital operations, marking a new era in
respiratory care.
For more information, please visit our corporate
website:
https://inspira-technologies.com/
Forward-Looking Statement Disclaimer
This press release contains express or implied
forward-looking statements under US Federal securities laws. These
forward-looking statements and their implications are based only on
the current expectations of the management of the Company. They are
subject to several factors and uncertainties that could cause
results to differ materially from those described in the
forward-looking statements. For example, the Company uses
forward-looking statements when it discusses the prospective
attendance to the J.P Morgan Healthcare Conference of its CEO and
President, the timing and expected FDA approval of its life support
device, its potential strategic advances, and the belief that some
in the industry are watching the Company's progress. Except as
otherwise required by law, the Company undertakes no obligation to
publicly release any revisions to these forward-looking statements
to reflect events or circumstances after the date hereof or the
occurrence of unanticipated events. More detailed information about
the risks and uncertainties affecting the Company is contained
under the heading "Risk Factors" in the Company's annual report on
Form 20-F for the fiscal year ended December
31, 2022, filed with the SEC, which is available on the
SEC's website, www.sec.gov.
For more details:
Public Relations
Manager
Adi
Shmueli
Inspira
Technologies
info@inspirao2.com
+972-9-9664485
Copyright © 2018-2023 Inspira Technologies OXY B.H.N.
LTD., All rights reserved.
Logo: https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/inspira-technologies-to-participate-in-jp-morgan-healthcare-conference-302017732.html
SOURCE Inspira Technologies